end,filed,form,Name,Ticker,CIK,Currency,AccountsPayableCurrent,AccruedProfessionalFeesCurrent,AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment,AdditionalPaidInCapitalCommonStock,AdjustmentsToAdditionalPaidInCapitalIncreaseInCarryingAmountOfRedeemablePreferredStock,AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue,AdjustmentsToAdditionalPaidInCapitalWarrantIssued,AllocatedShareBasedCompensationExpense,AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount,Assets,AssetsCurrent,AssetsFairValueDisclosure,CapitalExpendituresIncurredButNotYetPaid,CashAndCashEquivalentsAtCarryingValue,CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations,CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect,CommonStockCapitalSharesReservedForFutureIssuance,CommonStockParOrStatedValuePerShare,CommonStockSharesAuthorized,CommonStockSharesIssued,CommonStockSharesOutstanding,CommonStockValue,ComprehensiveIncomeNetOfTax,DeferredCosts,DeferredIncomeTaxLiabilities,DeferredOfferingCosts,DeferredRevenue,DeferredRevenueCurrent,DeferredRevenueNoncurrent,DeferredTaxAssetsGross,DeferredTaxAssetsInProcessResearchAndDevelopment,DeferredTaxAssetsNet,DeferredTaxAssetsOperatingLossCarryforwards,DeferredTaxAssetsOther,DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost,DeferredTaxAssetsValuationAllowance,DefinedContributionPlanCostRecognized,DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent,Depreciation,DividendsPreferredStockCash,EarningsPerShareBasicAndDiluted,EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate,EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance,EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential,EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent,EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes,EffectiveIncomeTaxRateReconciliationTaxCreditsResearch,EmployeeRelatedLiabilitiesCurrent,EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions,FinanceLeaseLiability,FinancialLiabilitiesFairValueDisclosure,GainLossOnDispositionOfAssets1,GeneralAndAdministrativeExpense,IncomeTaxExpenseBenefit,IncreaseDecreaseInAccountsPayable,IncreaseDecreaseInContractWithCustomerLiability,IncreaseDecreaseInOperatingLeaseLiability,IncreaseDecreaseInOtherCurrentAssets,IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets,InvestmentIncomeInterest,LeaseCost,LesseeOperatingLeaseLiabilityPaymentsDue,LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths,LesseeOperatingLeaseLiabilityPaymentsDueYearFive,LesseeOperatingLeaseLiabilityPaymentsDueYearFour,LesseeOperatingLeaseLiabilityPaymentsDueYearThree,LesseeOperatingLeaseLiabilityPaymentsDueYearTwo,LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear,LesseeOperatingLeaseLiabilityUndiscountedExcessAmount,Liabilities,LiabilitiesAndStockholdersEquity,LiabilitiesCurrent,NetCashProvidedByUsedInFinancingActivities,NetCashProvidedByUsedInInvestingActivities,NetCashProvidedByUsedInOperatingActivities,NetIncomeLoss,NetIncomeLossAvailableToCommonStockholdersBasic,NonoperatingIncomeExpense,OperatingExpenses,OperatingIncomeLoss,OperatingLeaseCost,OperatingLeaseExpense,OperatingLeaseLiability,OperatingLeaseLiabilityCurrent,OperatingLeaseLiabilityNoncurrent,OperatingLeaseRightOfUseAsset,OperatingLeaseWeightedAverageDiscountRatePercent,OtherAssets,OtherAssetsNoncurrent,OtherLiabilitiesCurrent,PaymentsForRepurchaseOfInitialPublicOffering,PaymentsOfStockIssuanceCosts,PaymentsToAcquirePropertyPlantAndEquipment,PreferredStockParOrStatedValuePerShare,PreferredStockSharesAuthorized,PrepaidExpenseAndOtherAssetsCurrent,ProceedsFromIssuanceInitialPublicOffering,ProceedsFromStockOptionsExercised,ProfitLoss,PropertyPlantAndEquipmentGross,PropertyPlantAndEquipmentNet,ResearchAndDevelopmentExpense,RestrictedCash,RestrictedCashNoncurrent,RetainedEarningsAccumulatedDeficit,RevenueFromContractWithCustomerExcludingAssessedTax,RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability,ShareBasedCompensation,ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate,ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice,ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice,ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice,ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice,SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1,SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit,StockholdersEquity,StockIssued1,StockIssuedDuringPeriodSharesStockOptionsExercised,StockIssuedDuringPeriodValueConversionOfConvertibleSecurities,StockIssuedDuringPeriodValueNewIssues,StockIssuedDuringPeriodValueStockOptionsExercised,SubleaseIncome,TemporaryEquityAccretionToRedemptionValue,TemporaryEquityAccretionToRedemptionValueAdjustment,TemporaryEquityCarryingAmountAttributableToParent,TemporaryEquityParOrStatedValuePerShare,TemporaryEquitySharesAuthorized,TemporaryEquitySharesIssued,TemporaryEquitySharesOutstanding,UnrecognizedTaxBenefitsIncomeTaxPenaltiesAccrued,ValuationAllowanceDeferredTaxAssetChangeInAmount,VariableLeaseCost,WeightedAverageNumberOfShareOutstandingBasicAndDiluted
2020-03-31,2020-05-28,10-Q,"Lyra Therapeutics, Inc.",LYRA,CIK0001327273,USD,1358000.0,590000.0,2837000.0,5208000.0,-85000.0,134000.0,740000.0,134000.0,9918182.0,40766000.0,35540000.0,0.0,49000.0,35247000.0,35576000.0,25439000.0,10193201.0,0.001,400000000.0,230860.0,230860.0,,-4232000.0,1650000.0,,,,,,,,,,,,,,,8000.0,0.0,-18.7,,,,,,,1019000.0,1500000.0,,0.0,,1284000.0,,432000.0,,,,-18000.0,16000.0,456000.0,3393000.0,,,379000.0,1124000.0,1091000.0,799000.0,282000.0,7350000.0,40766000.0,5158000.0,29464000.0,-8000.0,-4017000.0,-4232000.0,-4317000.0,16000.0,4248000.0,-4248000.0,263000.0,,3111000.0,919000.0,2192000.0,2963000.0,0.055,,,153000.0,,773000.0,8000.0,,,293000.0,,,-4232000.0,3121000.0,284000.0,2964000.0,300000.0,329000.0,-131989000.0,,,134000.0,0.78,0.015,438822.0,9.41,0.0,,109239.0,5.84,3366000.0,901678.0,6.84,,3366000.0,901678.0,6.84,,,8.63,1409000.0,,-126781000.0,,0.0,,,,,,85000.0,160197000.0,,,,,,,193000.0,230860.0
2020-06-30,2020-08-05,10-Q,"Lyra Therapeutics, Inc.",LYRA,CIK0001327273,USD,1146000.0,319000.0,2850000.0,223339000.0,-30000.0,619000.0,,619000.0,,92723000.0,89310000.0,0.0,,86599000.0,86928000.0,,3046467.0,0.001,200000000.0,12924563.0,12924563.0,13000.0,-4540000.0,,,,,,,,,,,,,,,,13000.0,,-0.56,,,,,,,1131000.0,6400000.0,,0.0,,2442000.0,,,,,,,5000.0,441000.0,3143000.0,,2000.0,382000.0,1127000.0,1095000.0,537000.0,242000.0,5900000.0,92723000.0,3942000.0,,,,-4540000.0,-4570000.0,5000.0,4545000.0,-4545000.0,264000.0,,2901000.0,943000.0,1958000.0,2755000.0,0.055,,,109000.0,,,,,,2711000.0,,,,3179000.0,329000.0,2103000.0,300000.0,329000.0,-136529000.0,,,,0.806,0.004,489383.0,9.33,0.0,,,10.71,5236000.0,1347394.0,10.24,,5236000.0,1347394.0,10.24,,,,2493000.0,,86823000.0,,0.0,160227000.0,57328000.0,,,,30000.0,,,,,,,,177000.0,8182725.0
2020-09-30,2020-11-10,10-Q,"Lyra Therapeutics, Inc.",LYRA,CIK0001327273,USD,530000.0,344000.0,2839000.0,223764000.0,,468000.0,,468000.0,,87330000.0,83555000.0,0.0,,81555000.0,81884000.0,,3046213.0,0.001,200000000.0,12924817.0,12924817.0,13000.0,-6334000.0,,,,,,,,,,,,,,,,33000.0,,-0.49,,,,,,,1593000.0,6300000.0,,0.0,,2651000.0,,,,,,,29000.0,442000.0,2875000.0,1095000.0,,2000.0,382000.0,1127000.0,269000.0,203000.0,6416000.0,87330000.0,4708000.0,,,,-6334000.0,-6334000.0,29000.0,6363000.0,-6363000.0,264000.0,,2672000.0,964000.0,1708000.0,2529000.0,0.055,,,109000.0,,,,,,2000000.0,,,,3756000.0,917000.0,3712000.0,300000.0,329000.0,-142863000.0,,,,0.828,0.003,571355.0,9.2,3000.0,,,9.12,5031000.0,1375307.0,10.34,,5031000.0,1375307.0,10.34,,,,2813000.0,,80914000.0,,,,-44000.0,1000.0,,,,,0.001,0.0,0.0,0.0,,,178000.0,12924682.0
2020-12-31,2021-03-09,10-K,"Lyra Therapeutics, Inc.",LYRA,CIK0001327273,USD,922000.0,555000.0,2878000.0,224363000.0,-115000.0,1813000.0,740000.0,1813000.0,1428886.0,80830000.0,75917000.0,0.0,205000.0,74593000.0,74922000.0,64785000.0,3038653.0,0.001,200000000.0,12932377.0,12932377.0,13000.0,-22127000.0,,624000.0,0.0,,,,42075000.0,5223000.0,624000.0,35729000.0,140000.0,322000.0,41451000.0,100000.0,0.03,95000.0,,-2.59,0.21,0.284,0.02,0.014,0.054,0.026,1892000.0,6200000.0,0.0,0.0,45000.0,9687000.0,0.0,345000.0,,-900000.0,118000.0,1013000.0,82000.0,1781000.0,2606000.0,1095000.0,,2000.0,382000.0,1127000.0,,167000.0,6338000.0,80830000.0,4884000.0,87703000.0,-1775000.0,-21143000.0,-22127000.0,-22242000.0,82000.0,22209000.0,-22209000.0,1055000.0,,2439000.0,985000.0,1454000.0,2301000.0,0.055,118000.0,118000.0,149000.0,2383000.0,,1775000.0,,,1324000.0,59892000.0,8000.0,-22127000.0,5043000.0,2165000.0,12522000.0,300000.0,329000.0,-149884000.0,,13000.0,1813000.0,0.807,0.006,626578.0,9.3,27000.0,124244.0,763505.0,9.66,5165000.0,1428886.0,10.41,,5165000.0,1428886.0,10.41,2.92,9.3,14.16,3099000.0,0.0,74492000.0,160227000.0,2814.0,160227000.0,57284000.0,8000.0,,,115000.0,,,,,,0.0,6300000.0,726000.0,8590205.0
2021-03-31,2021-05-11,10-Q,"Lyra Therapeutics, Inc.",LYRA,CIK0001327273,USD,1169000.0,523000.0,2948000.0,225224000.0,,599000.0,,599000.0,1762605.0,72917000.0,67351000.0,0.0,,66105000.0,66434000.0,-8488000.0,3590218.0,0.001,200000000.0,12962768.0,12962768.0,13000.0,-7802000.0,,,,,,,,,,,,,,,,70000.0,,-0.6,,,,,,,1213000.0,8400000.0,,0.0,,3061000.0,,452000.0,,,,-78000.0,29000.0,383000.0,2338000.0,1127000.0,,,2000.0,382000.0,827000.0,135000.0,5366000.0,72917000.0,4170000.0,262000.0,-1160000.0,-7590000.0,-7802000.0,-7802000.0,29000.0,7831000.0,-7831000.0,264000.0,,2203000.0,1007000.0,1196000.0,2069000.0,0.055,,,63000.0,,,1160000.0,,,1246000.0,,262000.0,-7802000.0,6116000.0,3168000.0,4770000.0,300000.0,329000.0,-157686000.0,,,599000.0,0.854,0.006,665936.0,9.39,200000.0,1590.0,365700.0,7.65,5540000.0,1762605.0,10.51,,5540000.0,1762605.0,10.51,8.63,11.7,10.75,3349000.0,,67551000.0,,30391.0,,,262000.0,,,,,,,,,,,119000.0,12945546.0
2021-06-30,2021-08-09,10-Q,"Lyra Therapeutics, Inc.",LYRA,CIK0001327273,USD,1899000.0,573000.0,3251000.0,226211000.0,,656000.0,,656000.0,,76332000.0,70073000.0,0.0,,69046000.0,69375000.0,,3551881.0,0.001,200000000.0,13001105.0,13001105.0,13000.0,-11039000.0,,,,12000000.0,,,,,,,,,,,,300000.0,,-0.85,,,,,,,1805000.0,7900000.0,,0.0,,3560000.0,,,,,,,26000.0,1507000.0,2064000.0,1127000.0,,,2000.0,382000.0,553000.0,106000.0,18833000.0,76332000.0,5904000.0,,,,-11039000.0,-11039000.0,26000.0,11065000.0,-11065000.0,264000.0,,1958000.0,1029000.0,929000.0,1834000.0,0.055,243000.0,,66000.0,,,,,,1027000.0,,,,7104000.0,3853000.0,7505000.0,300000.0,329000.0,-168725000.0,,,,0.847,0.009,719441.0,9.53,72000.0,,,5.49,2979000.0,1764499.0,10.42,,2979000.0,1764499.0,10.42,,,,2048000.0,,57499000.0,,,,,331000.0,,,,,,,,,,,1243000.0,12991837.0
2021-09-30,2021-11-09,10-Q,"Lyra Therapeutics, Inc.",LYRA,CIK0001327273,USD,2912000.0,831000.0,3601000.0,226955000.0,,733000.0,,733000.0,,67762000.0,60886000.0,0.0,,58131000.0,58460000.0,,3548408.0,0.001,200000000.0,13004578.0,13004578.0,13000.0,-11055000.0,,,,8300000.0,9841000.0,2145000.0,,,,,,,,,,400000.0,,-0.85,,,,,,,2244000.0,7500000.0,,0.0,,4018000.0,,,,,,,26000.0,1121000.0,1788000.0,1127000.0,,,2000.0,382000.0,277000.0,80000.0,20574000.0,67762000.0,17773000.0,,,,-11055000.0,-11055000.0,26000.0,11095000.0,-11081000.0,264000.0,,1708000.0,1052000.0,656000.0,1596000.0,0.055,245000.0,,130000.0,,,,,,2755000.0,,,,8307000.0,4706000.0,7077000.0,300000.0,329000.0,-179780000.0,14000.0,,,0.842,0.009,810221.0,9.75,21000.0,,,5.66,3742000.0,1850313.0,10.24,,3742000.0,1850313.0,10.24,,,,2577000.0,,47188000.0,,,,,11000.0,,,,,,,,,,,857000.0,13001514.0
2021-12-31,2022-03-09,10-K,"Lyra Therapeutics, Inc.",LYRA,CIK0001327273,USD,3125000.0,486000.0,3879000.0,227700000.0,,2733000.0,,2770000.0,1662861.0,54867000.0,47918000.0,,41000.0,45747000.0,46076000.0,-28846000.0,3545808.0,0.001,200000000.0,13007178.0,13007178.0,13000.0,-43513000.0,,356000.0,,,9789000.0,1926000.0,55053000.0,7288000.0,356000.0,46462000.0,73000.0,848000.0,54697000.0,200000.0,0.03,1001000.0,,-3.35,0.21,0.304,0.003,0.001,0.049,0.047,2429000.0,5700000.0,0.0,,,14206000.0,0.0,2350000.0,11715000.0,-986000.0,500000.0,847000.0,102000.0,5598000.0,1511000.0,1127000.0,,,2000.0,382000.0,,58000.0,20551000.0,54867000.0,18246000.0,359000.0,-3385000.0,-25820000.0,-43513000.0,-43513000.0,102000.0,43900000.0,-43615000.0,1056000.0,,1453000.0,1074000.0,379000.0,1355000.0,0.055,,762000.0,147000.0,,245000.0,3385000.0,,,2171000.0,,604000.0,-43513000.0,8382000.0,4503000.0,29694000.0,300000.0,329000.0,-193397000.0,285000.0,,2770000.0,0.85,0.007,856363.0,9.85,300000.0,122324.0,428500.0,6.89,918000.0,1662861.0,10.34,,918000.0,1662861.0,10.34,8.36,10.14,9.72,732000.0,0.0,34316000.0,,72201.0,,,604000.0,,,,,,,,,0.0,13200000.0,4542000.0,12986101.0
